BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10

• Press Releases

  Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

  October 10, 2025

   · 

  4 min read
• Press Releases

  SkinMedica® Debuts Reimagined Packaging and Unveils New HA5® Hydra Collagen Water Burst Moisturizer

  October 10, 2025

   · 

  12 min read
• Press Releases

  Apnimed to Participate in the 5th Annual Needham Private Biotech and MedTech Company Virtual 1x1 Forum

  October 10, 2025

   · 

  1 min read
• Press Releases

  Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

  October 10, 2025

   · 

  4 min read
• Press Releases

  Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy

  October 10, 2025

   · 

  5 min read
• Press Releases

  Enviro Tech, an Arxada Company, Launches Patented Breakthrough Technology for On-Site Generation of Peracetic Acid (PAA)

  October 10, 2025

   · 

  2 min read
• Press Releases

  Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting

  October 10, 2025

   · 

  9 min read
• Press Releases

  Immutep Announces Update for TACTI-004 (KEYNOTE-F91) Phase III Trial in First Line Non-Small Cell Lung Cancer

  October 10, 2025

   · 

  5 min read
• Press Releases

  ABLi Therapeutics Reports Final Results from the Phase 2 ‘201 Trial’ Evaluating Risvodetinib for the Treatment of Parkinson’s Disease

  October 10, 2025

   · 

  5 min read
• Press Releases

  Cidara Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for CD388 in Seasonal Influenza Prevention

  October 10, 2025

   · 

  4 min read